RARX News and Press, Ra Pharmaceuticals Inc. From 10/17/19

NEW YORK / ACCESSWIRE / October 17, 2019 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Ra Pharmaceuticals, Inc . (NASDAQ: RARX ) relate...

Merger activity decreased last week, with one new deal announced and seven deals closing. Deal Statistics: New Deals: The acquisition of Ra Pharmaceuticals ([[RARX]]) by UCB for $2.1 billion, or $48.00 per share in cash. Deal Updates: On October 8, 2019, Prosperity Bancs...

Allergan (NYSE: AGN ) resumed with Market Perform rating and $180 (7% upside) price target at Bernstein. More news on: Allergan plc, Amgen Inc., Biogen Inc., Healthcare stocks news, Stocks on the move, , Read more ...

NEW YORK , Oct. 11, 2019 /PRNewswire/ -- Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating: Dova Pharmaceuticals, Inc  ( DOV...

Biotech is in the doldrums. The SPDR S&P Biotech ETF  declined 18% in the past six months, and money continues to flow out of the sector. While several biotechs managed to IPO in September and October , it's not all roses. ADC Therapeutics pulled its plans to list citing market...

Stock market participants displayed a positive attitude on Thursday, apparently buoyed by signs that leaders of the U.S. and China will at least keep meeting in an effort to resolve their differences on trade issues. Major benchmark indexes were up by around half a percent on the day, and with e...

NEW YORK, Oct. 10, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Ra Pharmaceuticals, Inc. (NASDAQ: RARX) to UCB S.A. (“UCB”) for $48.00 per share is fair to Ra shareholders. On behalf of Ra shareholders, Halp...

Gainers : Ra Pharmaceuticals, Inc. (NASDAQ: RARX ) +100% . OncoSec Medical Incorporated (NASDAQ: ONCS ) +34% . ProPetro Holding Corp. (NYSE: PUMP ) +22% . Mereo BioPharma Group plc (NASDAQ: MREO ) +21% . Bed Bath & Beyond (NASDAQ: BBBY ) +20% . Caladrius Biosciences (NASDAQ: CLBS ...

Shares of Ra Pharmaceuticals (NASDAQ: RARX) , a clinical-stage biopharmaceutical company focused on rare diseases , jumped 101% as of 10:56 a.m. EST on Thursday. The huge move is a response to the news that Ra has agreed to be acquired by UCB (NASDAQOTH: UCBJF) , a global biopharmace...

Ra Pharmaceuticals (NASDAQ: RARX )  +102%  on being acquired by UCB SA. More news on: Ra Pharmaceuticals, Inc., OncoSec Medical Incorporated, Bed Bath & Beyond Inc., Stocks on the move, Read more ...